COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
Ivermectin in vitro study
6/30 In Vitro
Caly et al., Antiviral Research, doi:10.1016/j.antiviral.2020.104787 (Peer Reviewed) (In Vitro)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Source   PDF   Share   Tweet
In Vitro study showing that ivermectin is an inhibitor of SARS-CoV-2, with a single addition to Vero-hSLAM cells 2h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48h.

Caly et al., 6/30/2020, peer-reviewed, 5 authors.
Details of all 65 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit